Rejuvel Bio-Sciences, Inc.
NUUU
$0.00
$0.000.00%
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Revenue | 187.30K | 155.30K | 162.30K | 94.20K | 79.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 187.30K | 155.30K | 162.30K | 94.20K | 79.50K |
| Cost of Revenue | 98.50K | 88.50K | 89.60K | 83.30K | 29.90K |
| Gross Profit | 88.90K | 66.90K | 72.70K | 10.80K | 49.60K |
| SG&A Expenses | 1.35M | 1.28M | 841.40K | 698.00K | 691.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.45M | 1.37M | 930.90K | 781.20K | 720.80K |
| Operating Income | -1.26M | -1.22M | -768.80K | -687.20K | -641.50K |
| Income Before Tax | -1.05M | -549.30K | 1.79M | -352.90K | -734.80K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.05 | -0.55 | 1.79 | -0.35 | -0.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.05M | -549.30K | 1.79M | -352.90K | -734.80K |
| EBIT | -1.26M | -1.22M | -768.80K | -687.20K | -641.50K |
| EBITDA | -1.25M | -1.21M | -761.30K | -680.60K | -636.30K |
| EPS Basic | -0.02 | -0.01 | 0.01 | 0.00 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | 0.01 | 0.00 | 0.00 |
| EPS Diluted | -0.02 | -0.01 | 0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | 0.01 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 199.84M | 255.21M | 323.05M | 390.53M | 459.75M |
| Average Diluted Shares Outstanding | 199.84M | 255.26M | 324.33M | 391.81M | 461.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
